Cefpodoxime and Potassium Clavulanate Tablets

Pacitora Biotech proudly presents Pacidox-CV™, a advanced antibiotic combination of Cefpodoxime Proxetil (200mg) and Potassium Clavulanate (125mg). This fixed-dose combination is specifically designed to combat bacterial infections that have developed resistance to standard cephalosporin antibiotics.

Key Benefits:

• Overcomes Resistance – Clavulanate neutralizes beta-lactamase enzymes.

• Enhanced Potency – Up to 10x more effective than Cefpodoxime alone.

• Broad-Spectrum Cover – Effective against resistant Gram-positive & Gram-negative bacteria.

• Twice-Daily Dosing – Convenient 12-hourly schedule improves compliance.

• Treats Complicated Infections – Suitable for sinusitis, pneumonia, and recurrent UTIs.

FAQs:

1. Why is Potassium Clavulanate added to Cefpodoxime?
Potassium Clavulanate inhibits beta-lactamase enzymes that bacteria produce to destroy antibiotics. This allows Cefpodoxime to remain active and kill even resistant bacteria effectively.

2. How should I take Pacidox-CV tablets?
Take one tablet every 12 hours with food to improve absorption and reduce stomach upset. Swallow the tablet whole with a full glass of water – do not crush or chew.

3. What infections does Pacidox-CV treat?
It treats moderate to severe bacterial infections including sinusitis, pneumonia, bronchitis, complicated UTIs, and skin abscesses. It is especially useful when standard antibiotics have failed.

4. What are the common side effects?
Diarrhoea (most common), nausea, vomiting, abdominal pain, and oral thrush. Taking probiotics 2–3 hours after the antibiotic may help reduce diarrhoea.